
Cramer's Morning Take: Eli Lilly 8/26/25
Squawk on the Street
00:00
Advancements in GLP-1 Medication: A Shift from Injection to Oral Treatment
This chapter explores the significant progress in the creation of a GLP-1 pill, detailing its benefits over injectables, such as ease of manufacturing and improved patient comfort. It also considers the implications for medication compliance and healthcare logistics, while addressing concerns regarding effectiveness and spoilage.
Transcript
Play full episode